DE60133896D1 - Regulierung einer humanen transmembran-serinprotease - Google Patents

Regulierung einer humanen transmembran-serinprotease

Info

Publication number
DE60133896D1
DE60133896D1 DE60133896T DE60133896T DE60133896D1 DE 60133896 D1 DE60133896 D1 DE 60133896D1 DE 60133896 T DE60133896 T DE 60133896T DE 60133896 T DE60133896 T DE 60133896T DE 60133896 D1 DE60133896 D1 DE 60133896D1
Authority
DE
Germany
Prior art keywords
serine protease
transmembrane serine
human transmembrane
regulating
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133896T
Other languages
English (en)
Inventor
Yonghong Xiao
Richard Gedrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Application granted granted Critical
Publication of DE60133896D1 publication Critical patent/DE60133896D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60133896T 2000-06-13 2001-06-12 Regulierung einer humanen transmembran-serinprotease Expired - Lifetime DE60133896D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21122400P 2000-06-13 2000-06-13
US28335301P 2001-04-13 2001-04-13
US28364801P 2001-04-16 2001-04-16
PCT/EP2001/006618 WO2001096538A2 (en) 2000-06-13 2001-06-12 Regulation of human transmembrane serine protease

Publications (1)

Publication Number Publication Date
DE60133896D1 true DE60133896D1 (de) 2008-06-19

Family

ID=27395612

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133896T Expired - Lifetime DE60133896D1 (de) 2000-06-13 2001-06-12 Regulierung einer humanen transmembran-serinprotease

Country Status (7)

Country Link
US (4) US6734006B2 (de)
EP (1) EP1294903B1 (de)
AT (1) ATE394491T1 (de)
AU (1) AU2001276361A1 (de)
DE (1) DE60133896D1 (de)
ES (1) ES2305093T3 (de)
WO (1) WO2001096538A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
ATE278952T1 (de) * 1998-07-28 2004-10-15 Vlaams Interuniv Inst Biotech Leptin vermittelte geninduktion
AU8178401A (en) * 2000-05-22 2001-12-03 Vlaams Interuniv Inst Biotech Receptor-based interaction trap
US7235629B2 (en) * 2000-11-14 2007-06-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Functional fragment of the leptin receptor
US6794173B2 (en) * 2001-06-20 2004-09-21 Immunex Corporation Dendritic cell transmembrane serine protease
WO2004062656A1 (en) * 2003-01-10 2004-07-29 Universiteit Van Maastricht Compositions and methods for improving the condition of patients suffering from copd and other diseases
WO2004098487A2 (en) * 2003-05-05 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5)
CA2535859A1 (en) * 2003-08-14 2005-03-03 Dyax Corp. Endotheliase-2 ligands
EP1678317A2 (de) * 2003-10-17 2006-07-12 Bayer HealthCare AG Diagnostika und therapeutika für krankheiten, die mit dem mosaic serine protease (msp) assoziiert sind
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
JP5113519B2 (ja) 2004-07-08 2013-01-09 ヌームアールエックス・インコーポレーテッド 胸膜滲出の治療装置,治療方法及び材料
CA2585549A1 (en) * 2004-11-18 2006-05-26 Vib Vzw Novel type leptin receptor antagonist
JP2010504410A (ja) * 2006-09-20 2010-02-12 ヌームアールエックス, インコーポレイテッド 組織接着剤組成物およびその方法
EP2738198A1 (de) 2012-11-29 2014-06-04 Henkel AG & Co. KGaA Enzymatische Polyamidsynthese in wässriger Miniemulsion
KR101693243B1 (ko) * 2016-06-15 2017-01-05 재단법인 한국파스퇴르연구소 인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925521A (en) * 1997-03-31 1999-07-20 Incyte Pharmaceuticals, Inc. Human serine carboxypeptidase
ATE490977T1 (de) * 1998-06-01 2010-12-15 Agensys Inc Tumorantigen verwendbar in der diagnose und therapie von prostata und dickdarm-krebs
ATE397074T1 (de) * 1998-06-05 2008-06-15 Bayer Schering Pharma Ag Corin, eine serinprotease
AU4839999A (en) * 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
WO2001036645A2 (en) * 1999-11-17 2001-05-25 Curagen Corporation Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
CA2387805C (en) * 1999-11-18 2012-08-28 Corvas International, Inc. Nucleic acids encoding endotheliases, endotheliases and uses thereof

Also Published As

Publication number Publication date
WO2001096538A2 (en) 2001-12-20
US20040209327A1 (en) 2004-10-21
ATE394491T1 (de) 2008-05-15
EP1294903B1 (de) 2008-05-07
US6734006B2 (en) 2004-05-11
US20090182121A1 (en) 2009-07-16
US7314730B2 (en) 2008-01-01
WO2001096538A3 (en) 2002-06-06
EP1294903A2 (de) 2003-03-26
ES2305093T3 (es) 2008-11-01
AU2001276361A1 (en) 2001-12-24
US20020061850A1 (en) 2002-05-23
US20100069615A1 (en) 2010-03-18
US7622292B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
DE60133896D1 (de) Regulierung einer humanen transmembran-serinprotease
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
PT1202743E (pt) Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
RS30104A (en) Keratinocytes which may be used as a biologically active substance in the treatment of wounds
ATE182137T1 (de) Peptidylderivate als inhibitoren von metalloproteinase
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
NO20022318L (no) Nye forbindelser
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
CA2429679A1 (en) Hd3a gene inducing flowering of plant and utilization thereof
WO2001096378A3 (en) Human epithin-like serine protease
DE60034879T8 (de) Lantibiotikum
SG148034A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
DE60210297D1 (de) Verwendung von long pentraxin ptx3 für die behandlung von infertilität bei frauen
RS50075B (sr) Postupak za proizvodnju heterolognih proteinskih supstanci u biljnom materijalu
ATE317399T1 (de) Regulierung der menschlichen prostasin-änhlichen serine protease
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
WO2002000702A3 (en) Regulation of human epidermis-specific serine protease
WO2001079466A3 (en) Regulation of human epithin-like serine protease
DK1210446T3 (da) Modificeret ubiquitin-regulatorisk system
WO2001085959A3 (en) Regulation of human lysostaphin-like protease
WO2001062941A3 (en) Regulation of human gelatinase b-like enzyme 2
AU2002251788A1 (en) Novel compounds and uses thereof
White et al. Introduction to the ADAM family
WO2002012461A3 (en) Regulation of human membrane-type serine protease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE